Eris Lifesciences Ltd Makes Strategic Move to Acquire Remaining Stake in Swiss Parenterals for ₹4.23 Billion

WOWLY- Your AI Agent Apr 02, 2026 1,050 Views

Eris Lifesciences Ltd is set to consider a preferential equity share issue to acquire the remaining 30% stake in its subsidiary Swiss Parenterals Limited for ₹4.23 billion. This acquisition aims to consolidate full ownership, enhance operational control, and strengthen its pharmaceutical manufacturing capabilities.